This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
ATG16L1 · Western blot design guide
ATG16L1 Western Blot Planning Guide
Plan an ATG16L1 Western blot around the catalog-observed 68.3 kDa band, image-backed A00526-3 evidence, HPA controls, and verified protocol records.
Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
ATG16L1 Western Blot Experimental Design Guide
Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | 68.3 kDa | |
| Observed band | Not reported — verify product WB image | |
| Gel | 12-15% | |
| Positive control | Testis | |
| Negative control | Lymph node |
Important caveats
Reasons your observed band may differ from the expected size.
| ⓘ | Calculated mass | 68.3 kDa |
| ⓘ | Localization | Cytoplasm / Preautophagosomal structure membrane |
| ⓘ | Processing / PTM | Record-dependent |
| ⓘ | Reactivity | Human |
Section 1
Real Curated ATG16L1 Western Blot Protocols
Start with the molecular-weight rule, then compare verified publication-derived conditions.
| Sample / lysate | Bronchus |
| Gel % | 12-15% |
| Load | 20-30 µg total protein per lane |
| Transfer | Semi-dry, standard transfer |
| Membrane | 0.45 µm PVDF |
| Blocking | 5% non-fat milk or 5% BSA in TBST |
| Primary | A00526-3 at datasheet starting dilution |
| Primary incubation | Overnight at 4 °C with gentle agitation |
| Secondary | Species-matched HRP conjugate at validated dilution |
| Wash | 3 × 5 min in TBST |
| Detection | Chemiluminescent substrate |
| Exposure | Bracket exposures to avoid saturation |
Section 2
What Is the Expected ATG16L1 Western Blot Band Size?
Use the product-observed 68.3 kDa band as the primary planning value and retain the UniProt calculated mass as context.
| 68.3 kDa | Matches the authoritative product WB observation. |
| 68.3 kDa calculated | Use as UniProt context, not as a replacement observed band. |
| Unexpected additional signal | Do not assign identity without orthogonal positive/negative controls. |
💡Expected ATG16L1 appearancePlan around 68.3 kDa and keep the calculated mass as supporting context.
| Catalog-observed band | 68.3 kDa; use this as the primary experimental expectation. |
| Calculated mass | 68.3 kDa from UniProt Q676U5; retain as context. |
| Gel selection | 12-15%; shared with the recommended protocol and poster. |
| Specificity check | Compare the lead HPA positive and negative controls with A00526-3. |
| Situation | Likely cause | Next action |
|---|---|---|
| 68.3 kDa | Matches the authoritative product WB observation. | Confirm with orthogonal controls and the linked product record. |
| Additional band | May reflect processing, modification, or non-specific signal. | Run a dilution series and compare positive/negative controls. |
| Weak signal | Target abundance or transfer may be limiting. | Verify transfer, increase positive-control abundance, and bracket exposure. |
Experiment evidence
Western blot images showing ATG16L1 band
A00526-3 · ATG16L1
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for ATG16L1 Western blot
🧪Use Testis as the first positive-control candidate and Lymph node as the HPA Not detected negative candidate.
Positive control: Testis (High)
Negative control: Lymph node (Not detected)
HPA protein score determines control status; other expression data is supporting context only.
HPA tissue expression evidence for ATG16L1
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Testis | Reported tissue cells | High | Protein (HPA) | HPA → |
| Fallopian tube | Reported tissue cells | High | Protein (HPA) | HPA → |
| Kidney | Reported tissue cells | High | Protein (HPA) | HPA → |
| Bronchus | Reported tissue cells | High | Protein (HPA) | HPA → |
Section 3
Advanced ATG16L1 Western Blot Tips
Deeper troubleshooting and optimisation questions for ATG16L1, answered from its protein features.
Which band should guide the blot?
Use 68.3 kDa, the observation attached to the authoritative A00526-3 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 68.3 kDa expectation.
Which positive control should I start with?
Start with Testis, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Lymph node as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for ATG16L1 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A00526-3 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents
ATG16L1 Western Blot Reagents
Human-reactive ATG16L1 Western blot reagents with authoritative product imagery.
Real WB data
Anti-ATG16L1 Antibody Picoband®
Cat # A00526-3
Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.
Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.
References
- UniProt Q676U5
- Human Protein Atlas — ATG16L1
- A00526-3 product record
- PMC11050548 — Missing WD40 Repeats in ATG16L1 Delays Canonical Autophagy and Inhibits Noncanonical Autophagy (International journal of molecular sciences, 2024)
- PMC5813257 — The WD40 domain of ATG16L1 is required for its non-canonical role in lipidation of LC3 at single membranes (The EMBO journal, 2018)
- PMC12023798 — Macrophage ATG16L1 promotes liver regeneration after partial hepatectomy (JHEP reports : innovation in hepatology, 2025)